Prescription disease-modifying therapy capsule for relapsing-remitting multiple sclerosis in ages 10+
Finlim 0.5 mg is a disease-modifying therapy (DMT) used to treat relapsing-remitting multiple sclerosis (RRMS) in adults and children aged 10 years and older. It reduces relapse rates and slows disease progression, and is recommended for highly active patients or those not responding to other DMTs.
Key Features:
• Reduces relapse frequency
• Slows disability progression
• Effective in highly active or advanced RRMS cases
Warnings: Contraindicated during pregnancy or in women of childbearing potential not using effective contraception. Not to be used in patients with immunodeficiency, serious liver disease or certain cardiac conditions. Cardiac and liver assessments are required before initiation. Stop treatment if serious infection, visual disturbance or liver issues occur. Must be prescribed and monitored by a physician experienced in MS treatment; first-dose monitoring is required to manage possible heart rate changes. Store in a cool, dry place away from direct sunlight. This is a prescription medicine; use only under a physician's supervision.
Size: 30 capsules
Attributes
Product Content
How to Use:
• Take one 0.5 mg capsule orally once daily, with or without food
The link to Finlim 0.5 mg 30 Capsules has been copied